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Background. Most patients do not undergo acute reperfusion after myocardial infarction, and which of these patients should undergo coronary angiography is still debated.
Methods and Results. We analyzed the l-year clinical outcomes and rates of coronary angiography performed as late as 60 days after myocardial infarction in 3,804 patients admitted between 1979 and 1988 and followed in six different centers. Patients less than 75 years old were classified into low-, medium-, and high-risk groups using a multivariate analysis of historical and clinical variables gathered during the first 8 hospital days. Patients who underwent early reperfusion (17%, all after 1984) were analyzed separately. To analyze time trends, patients were compared before and after mid-1984. Mortalities from day 9 through 1 year were similar for the two time periods in the low-(3.3% versus 2.5%) and medium-risk (7.4% versus 5.6%) groups, but mortality was lower for the high-risk group after 1984 (31.6% versus 20.0%). The proportion of patients undergoing coronary angiography increased dramatically in each group after 1984 (low risk, 18% versus 48%; medium risk, 23% versus 49%o; high risk, 10%o versus 32%, before and after 1984, respectively). Furthermore, a large percentage of patients (more than 40%) in the low-risk group did not have at least one of the indications for coronary angiography recently recommended by a joint task force. Among patients undergoing coronary angiography, the proportion of patients with three-vessel coronary artery disease decreased after 1984, whereas the proportion undergoing mechanical revascularization in the year after infarction increased in all risk groups. Conclusions. Despite the recent development of noninvasive techniques with high sensitivity for detecting high-risk patients after myocardial infarction, coronary angiography is being performed increasingly in all patients, including those determined to be at low risk for complications based on clinical data. The economic consequences of such a trend could be considerable, and its impact requires careful analysis. (Circulation 1991; 84:1004 -1015 T his year, as many as 1.5 million Americans will experience an acute myocardial infarction.1 Of those who survive to be discharged from the hospital, approximately 10% will die within the following year. Identification of high-risk individuals who may benefit from more aggressive medical or surgical treatment has been the subject of many studies. Ideally, the application of noninvasive techniques such as electrocardiographic exercise testing,7-13 exercise with radionuclide studies14-17 or echocardiography,1819 or positron emission tomography20'21 should allow the identification of patients at high risk who might benefit from mechanical or surgical recanalization and therefore should undergo cardiac catheterization.22 27 However, despite support and guidelines for the use of noninvasive techniques as a first step in risk stratification after acute myocardial infarction,28 an increasing proportion of patients undergo cardiac catheterization every year, even patients at low risk for complications or death after hospital discharge. This practice may be a result of a lack of consensus concerning when the test is appropriate and a lack of confidence in the results of noninvasive testing.
We have developed a risk stratification scheme based on multivariate analyses of clinical and historical variables that can define groups of patients at low, medium, and high risk after myocardial infarction. Although such methods are cumbersome and often replaced by simpler decision schemes to assess risk in the clinical setting,22-26 the stratification provided is advantageous as a research tool for assessing trends in the management of patients after myocardial infarction within fairly homogenous subgroups.
Accordingly, the main purpose of the present study was to assess recent trends in the use of coronary angiography in the convalescent phase of myocardial infarction in a large patient population stratified according to risk. In addition, the indications for coronary angiography and the yield on coronary angiography of patients with significant coronary artery disease within each risk group were analyzed.
Methods

Patient Population
In the period from January 1979 through October 1988, 3,804 patients who suffered an acute myocardial infarction were included in this analysis. These patients were admitted within 24 hours of symptom onset and survived the first 8 days of hospitalization. The diagnosis of Q wave myocardial infarction was made when the development of new Q waves on the electrocardiogram was accompanied by either typical chest pain or creatine kinase elevation (twice the laboratory upper limit of normal). The diagnosis of non-Q wave myocardial infarction was established by the presence of ST segment depression or T wave inversion and creatine kinase elevation. Exclusion criteria were the refusal to sign a consent form (n=61) and coronary bypass surgery performed within 1 week of admission (n=12, before August 1984 only).
For the analysis of time trends, patients were divided into two groups according to whether they were admitted before (n=1,839) or after (n=1,965) August 1984 Follow-up Patient follow-up was performed at 3, 6, and 12 months after hospital admission. Information concerning death was obtained from the death certificate and hospital records. Telephone interviews with personal physicians or family members were sometimes made to clarify details. All data were reviewed by a research physician; when any doubt existed as to the cause of death, a committee reviewed the available data and came to a consensus decision. Death was considered cardiac in cause when secondary to a new myocardial infarction, extension of the myocardial infarction, congestive heart failure, shock, cardiac procedures, or surgery and when sudden (resulting from fatal arrhythmias or sudden unexpected death with exact cause unknown but presumed to be cardiac). One-year follow-up was obtained in 97% of the patients eligible for follow-up at the time of this analysis.
Risk Stratification Scheme
More than 60 clinical variables were screened univariately for association with the end points of cardiac death or new myocardial infarction occurring from day 9 to 1 year. Variables univariately significant by t test (continuous variables) or y2 (categorical variables) at the p<0.05 level were submitted to a two-stage multivariate analysis (see "Appendix").
Stage 1: Identification of low-risk patients. All patients with serious in-hospital complications were excluded from the first stage of the analysis. These complications included malignant arrhythmias such as ventricular fibrillation or tachycardia (see "Appendix"), congestive heart failure, shock, persistent ischemic pain, or intact extension beyond 24 hours. Multivariate analyses, including data acquired from the history and the first 3 hospital days, were used to build a scheme for the identification of patients at low risk of new myocardial infarction or death within the first 3 months. The purpose of using data from only the first 3 days of hospitalization was to identify low-risk patients early so that early hospital discharge could be considered in the future. Three different multivariate methodologies (linear discrimination analysis,31 logistic regression,32 and recursive partitioning33) were used; using a conservative approach, a patient had to be considered at low risk by all three methodologies before being placed in the low-risk group. The variables selected by these multivariate methodologies and the prognostic functions are given in the "Appendix."
Stage 2: Identification of high-and medium-risk patients. Patients with complications before day 8 and those who were not identified as low risk during the first stage of the multivariate analysis were subjected to a second-stage multivariate analysis based on data from the history and the first 8 days of hospitalization. The end point for this analysis was cardiac death within 1 year. Again, three multivariate methodologies were used, and patients were assigned to the high-risk group if at least two of the three methods predicted high risk. All patients not classified as high risk were placed in the medium-risk group. Variables selected for this analysis and the prognostic functions are given in the "Appendix." Patients admitted before August 1984 were risk stratified retrospectively based on the multivariate risk stratification scheme described above, which was developed using the first half of this population. Risk stratification was performed prospectively on patients admitted since August 1984. Thus, to be assigned to a risk group, a patient needed to survive the first 8 days, and such patients constitute the present study population.
Risk Groups
For patients less than 75 years old admitted before August 1984, 21% were low risk, 55% were medium risk, and 24% were high risk. For all patients admitted subsequently, regardless of whether there was an acute intervention, 26% were low risk, 45% were medium risk, and 27% were high risk. The reduction in medium-risk patients from 55% to 45% of the population was statistically significant (p<0.001) and reflects the inclusion of two new centers in the later cohort with lower-risk patients and high rates of acute interventions. Among the patients in the second cohort less than 75 years old with an acute intervention, 37% were low risk, 44% were medium risk, and 19% were high risk. Figure  2 (top panel); the yearly rate from 1979 through 1989 is shown in Figure 2 (bottom panel). In the early cohort, less than one fourth of patients from each risk group (18%, 23%, and 10% for the low-, medium-, and high-risk groups, respectively) underwent cardiac catheterization. However, in the later cohort, nearly half of the patients in the low-(48%) and medium-risk groups (49%) and a third of the highrisk group (32%) underwent coronary angiography within 60 days. The yearly rates of coronary angiography were low before 1985, increased substantially to a peak of 52% in 1987, and has decreased since then (Figure 2, bottom panel) . Revascularization procedures during the year after myocardial infarction were performed more than twice as often in the later cohort regardless of risk group (each,p<0.01) (Figure 3) Table 2 for each risk group in both the early and later cohorts. As shown, in 40% of low-risk patients who underwent coronary angiography within 60 days, none of the indications mentioned above could be documented. Recall that patients in the low-and medium-risk groups had the highest rates of coronary angiography (Figure 2 ). Also, a majority of patients in the low-(69%) and medium-risk (70%) groups of the early cohort did not undergo exercise testing before coronary angiography; these proportions increased in the later cohort to 74% and 78% for the low-and medium-risk groups, respectively.
Results of Coronary Angiography
The incidence of three-vessel and left main coronary artery disease is shown in Figure 4 by risk group for each cohort. In the early cohort, a higher proportion of patients who underwent coronary angiography had three-vessel disease in all three risk groups ( Figure 4 , top panel) (34%, 44%, and 67% for the low-, medium-, and high-risk groups, respectively). In the later cohort, 16% of patients who underwent coronary angiography in the low-risk group, 25% in the medium-risk group, and 38% in the high-risk group had three-vessel disease (Figure 4 , top panel). However, there was no significant difference in the incidence of left main coronary artery disease be- 
Patients Less Than 75 Years Old Undergoing Acute Thrombolysis and/or Acute Revascularization
In the later cohort, 331 patients had acute thrombolysis and/or angioplasty or coronary artery bypass surgery within 24 hours of admission. In-hospital mortality after day 8 was 0.3%, and 1-year postdischarge mortality rate was 3.4%. This subgroup of patients was younger and had less history of coronary artery disease than the other patients in the later cohort (Table 1) . More than 90% had coronary angiography and more than 40% underwent a revascularization procedure in the first year after the acute intervention.
Discussion
The present study documents that the use of coronary angiography after myocardial infarction has markedly increased in recent years and that this increase is present in all risk groups, including patients at low risk for death within the year after infarction. The yield of patients with left main or three-vessel disease was 16% in the low-risk group. A smaller proportion of patients was selected for coronary angiography in the early cohort, and these patients had more extensive disease (Figure 4 , top panel), regardless of risk group. However, with a higher proportion of patients undergoing coronary angiography, it is expected that the yield of patients with significant disease would decrease, and this finding does not indicate a lower underlying prevalence of significant disease. Mortality decreased only slightly for the low-and medium-risk groups ( Figure  1, top panel) between the two cohorts despite the increased rate of coronary angiography (Figure 2 , top panel) and increased use of revascularization procedures, mainly PTCA (Figure 3) . To detect the observed decrease in mortality from day 9 through 1 year between the two cohorts for the low-risk group (3.3% to 2.5%) with 90% power and a one-tailed significance level of 0.05 would require 7,783 patients in each cohort. Whether the decrease in mortality in the high-risk group of the later cohort is a result of more intervention, better medical care without intervention, or differences in patient populations is uncertain. It is interesting to note that the percent of patients undergoing coronary angiography was the lowest in the high-risk group. Patients who underwent early thrombolysis or coronary angioplasty were analyzed separately because several randomized trials have already attempted to define the role and timing of coronary angiography in those individuals.34-36 However, this group of patients may include only approximately 15% of patients presenting with symptoms suggesting acute myocardial infarction. 37 The role of coronary angiography remains much less clear in the remaining patients who do not undergo acute thrombolysis or early mechanical revascularization, and they are the main subject of this study.
Indications for Coronary Angiography
The results suggest that a large percentage of patients undergoing coronary angiography do not have indications as recommended recently by a subcommittee of the Joint Task Force on Cardiovascular Procedures and Therapy of the American College of Cardiology and the American Heart Association.27
These criteria included resting ischemic pain, clinical heart failure, radionuclide left ventricular ejection fraction of less than 0.45, exercise-induced ischemia, age of less than 40 years, and non-Q wave myocardial infarction. Non-Q wave infarction and age of less than 40 years were listed among indications considered controversial in the Task Force report.27 Nevertheless, 41% of the patients in the low-risk group of our 1984-1988 cohort who underwent coronary angiography within 60 days did not have at least one of these indications for coronary angiography after myocardial infarction.
It is recognized that the final decision to perform coronary angiography in a given patient will not rely on a risk stratification scheme and will be individualized. It is likely that some patients determined to be at low risk by multivariate analysis after myocardial infarction may have had a valid reason for this procedure and benefitted from cardiac catheterization and coronary revascularization. In the 1984-1988 cohort of our study, 16% of low-risk patients who underwent cardiac catheterization had threevessel or left main coronary artery disease, and 11% underwent coronary bypass surgery at some time during the first year. Whether this rate of yield justifies the use of coronary angiography as a routine screening procedure is a matter of opinion. In addition, not all patients with multivessel involvement after myocardial infarction have a poor prognosis. Furthermore, coronary angiography may not allow accurate prediction of the site of subsequent myocardial infarction, which often occurs in arteries showing minor rather than high-grade stenoses. 38 Likewise, functional abnormalities detected by treadmill testing coupled with radionuclide studies may be more valuable than anatomy alone for predicting prognosis after myocardial infarction. '5-17 It is intriguing that the use of coronary angiography has increased greatly at a time when multiple studies have shown the value of various noninvasive methods for detecting high-risk patients after myocardial infarction. Recent years have also witnessed the extraordinary development of multiple new methods in interventional cardiology, including PTCA, atherectomy, stenting, and so on. Therefore, the trend toward a more mechanistic approach to the therapy of coronary artery disease may explain the increased use of coronary angiography. When acute intervention became prevalent, there was a dramatic increase in the use of coronary angiography, even among patients without acute intervention (Figure 2 , bottom panel). Concomitant with the publication of reports indicating coronary angiography is not essential after thrombolysis,36,39 the rate of coronary angiography has decreased but is still higher than in the era before acute intervention. Also, financial incentives for hospitals as well as for some physicians might explain in part the increased recent trend in the use of coronary angiography. Our study cannot assess the cost-benefit ratio of the observed trend in the use of coronary angiography because benefits cannot be adequately evaluated from a retrospective study. It is possible that after myocardial infarction some low-risk patients may benefit from revascularization, particularly those with multivessel involvement and residual ischemia,4041 those with multivessel disease and left ventricular dysfunction at rest,42,43 and perhaps, as recently suggested, those with persistent total occlusion of the infarct-related artery. 44 A striking finding of our study was that a majority (approximately 75%) of patients in the low-or medium-risk group did not undergo exercise testing before coronary angiography. In our study, these tests were done only if requested by the attending physician. It is possible, therefore, that performance of routine exercise testing would allow better detection of patients with significant three-vessel or left main coronary artery disease who are at risk of recurrent events, as suggested by many previous studies7-19 and by recent risk stratification schemes.22-26 For instance, since 1984, 16% of patients in the low-risk group who underwent coronary angiography had three-vessel coronary disease, but only 11 of 26 patients (42%) with three-vessel coronary artery disease at cardiac catheterization in the low-risk group underwent exercise testing. Of those, four had a positive exercise test, four had a negative exercise test, and in three patients the test was indeterminant because of failure to achieve adequate exercise level. Of the nine patients in the low-risk group with left main coronary disease, only four underwent exercise testing, three of which were positive. The inability of exercise testing to detect all patients with three-vessel or left main disease may be a weakness of a decision strategy based on such noninvasive evaluation of low-risk patients. However, it has been shown that in patients with significant coronary artery disease, those with an abnormal exercise test response are at particularly high risk for subsequent events. On the other hand, patients with good exercise test responses may have a good outcome despite the presence of multivessel coronary disease. '5-'7,45-49 Decision schemes for the use of coronary angiography after myocardial infarction have been proposed.22-26 Whether such schemes, which use exercise testing and noninvasive assessment of residual left ventricular function as a first step in the evaluation of uncomplicated patients, can identify those at increased risk at a rate comparable to that from elective coronary angiography remains to be demonstrated. Even though some high-risk patients may not be detected, such schemes may avoid unnecessary diagnostic and therapeutic procedures with their associated morbidity and mortality in patients at low risk after myocardial infarction.
The goal of our study was to document the trends and results of coronary angiography in patients from several urban, military, and university centers grouped according to risk after myocardial infarction. It is recommended that the marked trend toward increased use of coronary angiography documented in our study be evaluated nationally by cost-benefit analysis because of the very significant consequences of the cost of health care.
First Stage
The end points used in the multivariate analyses were death or new nonfatal myocardial infarction from day 9 through day 90 after admission. 
Second Stage
The end point for the multivariate analyses was cardiac death from day 9 through 1 year after admission. Table 5 shows the variables and coefficients for the linear and logistic discriminant functions. For the linear discriminant function, if the sum of the variables and their respective coefficients is more than 3.218, then the patient is at high risk by this methodology. For the logistic function, the quantities F and p, the probability of no event, are computed like in stage 1. Ifp<0.7800, the patient is at high risk by this methodology. For recursive partitioning, if the maximum blood urea nitrogen value is more than 26.5 mg/100 ml, then the patient is considered at high risk. Otherwise, if the patient is older than 49.5 years and the grade of pulmonary congestion on the chest radiograph is more than 2 (see legend to Table 5 ), then the patient is considered at high risk.
To be classified into the high-risk group, a patient must be so classified by two of the three multivariate methodologies. Patients undergoing the second-stage computation who are not classified at high risk are placed in the medium-risk group. Thus, patients surviving the first 8 days can be classified into one of three risk groups.
A simple computer program can be written that accepts the values of the variables as input and then displays the resultant risk group of the patient.
